Theaflavin compositions, related processes and methods of use
AssigneeJiahgsu Dehe Bio-Tech Co., Ltd
InventorsXiaowei Shi, Xueyin Ren, Jianhong Liu, Houjian Cao, Wenhao Ren, Yizhou Cao
Life of this patent
Estimating the term…
Loading patent…
AssigneeJiahgsu Dehe Bio-Tech Co., Ltd
InventorsXiaowei Shi, Xueyin Ren, Jianhong Liu, Houjian Cao, Wenhao Ren, Yizhou Cao
Estimating the term…
A process for producing purified theaflavin extract is provided which comprises combining an organic solvent with tea leaves, extracting polyphenols from the tea leaves to produce an organic stock substrate solution; producing a second batch of tea leaves; grinding the second batch of tea leaves to produce stock fermentation enzyme; combining the stock substrate solution with the stock fermentation enzyme to produce a fermentation mixture; fermentation of the mixture to produce theaflavins; and, separating the theaflavins from the fermentation mixture to produce purified theaflavin extract. Oral dosage forms are provided which comprise an effective amount of the purified theaflavin extract. Methods of treatment of human physiological disorders are provided which comprise administering an oral dosage form.
A process for producing theaflavin extract comprising
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Magnoliopsida: theaceae , e.g. camellia
Having six-membered rings with one oxygen as the only ring hetero atom: not condensed with another ring
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
Drugs for disorders of the metabolism: antihyperlipidemics
About 3 years 3 months of term left · ends 18 Jan 2030 (estimated)
The present invention relates to processes for production of purified theaflavin extract, compositions which result from the processes, oral dosage forms, and methods of use.
Theaflavin (catechin dimer joined at B rings) and its derivatives, known collectively as theaflavins, are antioxidant polyphenols Flavan-3-ols formed from catechins during enzymatic oxidation (fermentation). Theaflavins generally comprise a mixture of theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin-3,3′-digallate.
Theaflavins have positive health benefits directly linked to the antioxidant properties of these compounds. The benefits include the ability to effect lower blood lipid levels (e.g. cholesterol), control of inflammation, as well as anti-tumor effects. See, e.g., Maron D J, et al., Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: a Randomized Controlled Trial, Arch. Intern. Med. 163 (12): 1448 (2003). See, also, Lorentz, M., et al., Basic Res Cardiol. 2009 January; 104(1):100; Manna, S., et al., J Nutr Biochem. 2009 May; 20(5):337.
FIG. 1 displays a process embodiment of the present invention for manufacturing theaflavins.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of skill in the art to which this invention belongs. All publications and patents referred to herein are incorporated by reference including U.S. Pat. Nos. 7,427,622; 7,157,493 and 7,288,680.
As used herein the term organic solvent refers to any inert organic solvent that solubilizes tea leaf polyphenols including but not limited to esters, alcohols, ketones and ethers. The term inert as used herein refers to an organic solvent that does not otherwise affect the oxidation of polyphenols to theaflavins in the processes described herein. Esters for use as organic solvent in processes described herein include, but are not limited to, for example, methyl acetate, ethyl acetate, propyl acetate, and isopropyl acetate. Alcohols for use as organic solvent in processes described herein include, but are not limited to, for example, ethyl alcohol, propyl alcohol, and isopropyl alcohol. Ketones for use as organic solvent in processes described herein include, but are not limited to, for example, acetone and butanone. Ethers for use as organic solvent in processes described herein include, but are not limited to, for example, diethyl ether, dipropyl ether, and methyl-tert-butyl ether.
The term organic stock substrate solution, as used herein, refers to an organic tea leaf extract containing polyphenols.